Personalized treatment for thymus regeneration and immune system restoration

Is this trial a fit for you?

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

The TRIIM-X trial is an expanded pilot clinical study designed to evaluate a personalized combination treatment regimen aimed at regenerating the thymus, a crucial component of the immune system that deteriorates with age. This study will assess biomarkers related to epigenetic aging and immunosenescence, while also monitoring established clinical measures and risk factors for various age-related diseases. Participants will receive a combination of recombinant human growth hormone, metformin, and DHEA, tailored to their individual needs, similar to the previous TRIIM trial that showed promising results. The goal is to prevent or reverse aspects of aging and improve overall health outcomes in older adults.

Why it matters

Who can join: the full rules

Inclusion Criteria:

* Male or female volunteers
* Aged 40 to 80 years, inclusive
* All ethnicities
* Able to participate in 12-month study
* Able to provide informed consent

Exclusion Criteria:

* Malignancies or high risk of malignancy, as suggested by familial risk or personal medical history
* Premenopausal women
* Postmenopausal women on HRT
* IGF-1 levels \< 90 ng/ml or \>300 ng/ml
* Diagnosed or suspected growth hormone resistance
* Known growth hormone deficiency based on stimulation testing
* Pre-existing carpal tunnel syndrome
* Significant arthritis/arthralgia/joint swelling
* Bradycardia (\<55 bpm), significant hypertension (systolic \>160 mmHg, or diastolic \>90 mmHg) despite treatment, serious angina, or other serious cardiovascular disease or cardiovascular disease risk factors
* Excessive skin growths (e.g., flat warts) without cryosurgical options
* BMI of 35 or greater
* PSA level above the age-adjusted normal range for reasons other than confirmed prostatitis
* Testosterone levels above the upper limit of normal
* Levels of C-reactive protein (CRP) above the upper limit of normal
* Type 1 or pre-existing Type 2 diabetes
* Uncorrected hypothyroidism
* HIV infection
* Allergy or other sensitivity to study medications
* Other unstable medical conditions
* Use of GH within the last 5 years
* Participation in a clinical research trial within 30 days prior to enrollment
* Use of chronic glucocorticoid therapy
* Unwilling to discontinue androgen supplementation if testosterone levels are above the upper limit of normal
* Ongoing treatment with carbonic anhydrase inhibitors
* Ketogenic diet, calorie-restricted diet, or prolonged fasting, without willingness to discontinue these diets or adhere to an alternative diet during the study
* Alcoholism or drug addiction
* Smoking or unwillingness to quit smoking
* Cognitive impairment, illiteracy, inability or unwillingness to give voluntary informed consent

Where it's running

• Intervene Immune
  Torrance, California, United States Recruiting

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

• Influenza Vaccine Immunogenicity in Older Adults with Repeated Vaccination

  This study tests how different flu vaccines perform in adults 65+ who get yearly vaccines to see if age and repeated vaccination affect the immune response.

  Recruiting Phase 4 Korea University Guro Hospital · Seoul · NCT07838298

• Preserving sperm quality with aging through cryopreservation

  This study tests whether freezing and thawing sperm can help keep younger-like DNA and molecular traits in men as they age.

  Recruiting IVI Murcia · Murcia, Murcia · NCT07814235

• Infection and Immune Aging in Older Adults: A Look at How Immunosenescence Relates to Infections

  This study will follow people aged 60 and up to see how aging immune systems relate to infections, comparing healthy seniors with those who have infections.

  Recruiting Huashan Hospital · Shanghai, Shanghai Municipality · NCT07672522

• Microbiota Interventions for Accelerated Aging in People with HIV on Alcohol

  This study tests whether two safe dietary supplements—Limosilactobacillus reuteri and blueberry extract—can affect immune aging markers in people with HIV who recently used alcohol.

  Recruiting Phase 1/2 Louisiana State University Health Sciences Center in New Orleans · New Orleans, Louisiana · NCT07462767

• Probiotic drink for skin inflammation during the menopausal transition

  This study will test whether a daily Lactobacillus casei Shirota probiotic drink can reduce inflammation and improve immune and skin health in women aged 40–60 going through the menopausal transition with inflammatory facial skin conditions.

  Recruiting King's College London · London, London · NCT07341087

• Effects of a fasting-mimicking 5-day program and a Longevity Diet on age-related risk factors and aging biomarkers

  This trial will test whether a 5-day fasting-mimicking diet, alone or combined with a Longevity Diet, helps improve body weight, body composition, cardiovascular risk markers, and aging-related biomarkers in adults aged 30–65, many of whom are overweight or have metabolic risk.

  Recruiting Fondazione Valter Longo · Varapodio, Calabria, Italy · NCT07255300

How to take part

1. Review the eligibility criteria above with your treating physician.
2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.